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Abstract 
The intravitreal route faces many challenges in rapidly and effectively reaching posterior eye 
pathology, with administered therapeutics experiencing non-specific distribution around and 
premature clearance from ocular tissues. Nanobubbles and ultrasound may improve outcomes 
of intravitreally administered drugs by influencing the directionality of drug-containing 
particle migration. In this study, we assessed the impact of trans-scleral or corneal ultrasound 
application on the distribution of intravitreally-injected nanobubbles. Rhodamine-tagged gas 
entrapped nanobubble formulations were prepared and injected into ex vivo bovine and 
porcine eyes and subjected to ultrasound (1 MHz, 0-2.5 W/cm
2
, 50-100% duty, 60 s). Bovine 
eyes were partially dissected to visualize the vitreous humor and particle migration was 
evaluated via optical fluorescence spectroscopy. Directional migration in porcine eyes was 
evaluated using a snap freezing protocol complemented by quantification of regional 
fluorescence. The impact on nanobubble migration following pars-plana injection and 
sequential ultrasound cycle application from scleral or corneal-surface positions was also 
assessed. Administration of ultrasound significantly enhanced the directional migration of 
nanobubbles in both ex vivo models, with multiple corneal ultrasound cycles promoting 
greater migration of dye-filled nanobubbles to posterior regions of the vitreous. Moreover, 
particles moved in a directional manner away from the ultrasound wave source demonstrating 
an ability to effectively control the rate and path of nanobubble migration. These findings 
establish an encouraging new and safe modality enabling rapid distribution of intravitreally-
injected therapeutics where expeditious therapeutic intervention is warranted. 
 
Keywords: Ultrasound; Nanobubbles; Intravitreal drug delivery; Ocular drug delivery; Ex 
vivo 
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Abbreviations 
5-TAMRA   5-carboxy-tetramethylrhodamine N-succinimidyl ester 
AMD    Age-related macular degeneration 
DPPC    1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
DR    Diabetic retinopathies 
DSPE-PEG(2k)-OMe  1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethylene glycol)-2000] 
PFP    Perfluoropropane 
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1 Introduction 
Diseases of the posterior eye pose an immense burden on global healthcare systems [1, 2]. 
Age-related macular degeneration (AMD), diabetic retinopathy (DR) and glaucoma are three 
such examples, with each being listed among the top 10 priority eye diseases by the World 
Health Organization [3]. At present, treatment options for these diseases are limited; late 
stage AMD and DR are treated with intravitreal injections of antibody-based therapeutics 
typically administered every 4-6 weeks [4, 5] whereas glaucoma is managed by intraocular 
pressure lowering eye drops [6]. In all cases, the delivery of treatments to the target tissue has 
been sub-optimal. 
A substantial factor limiting therapeutic efficacy is the location of posterior eye pathologies. 
These diseases affect numerous layers of the retina and although intravitreal drug delivery 
can attain a higher dose of therapeutic in these layers when compared to other conventional 
ophthalmic routes [7, 8], still only a fraction of the administered dose reaches its target [9]. 
This is due to the influence of convective flow [10, 11], non-specific diffusion [12] and 
saccade [13, 14] on drug migration, with each of these factors hastily displacing the injected 
bolus. While it has been proposed that injecting therapeutic closer to the target site via deeper 
injection will enhance migration towards and uptake by target tissue [15], this remains 
controversial due to the heightened risk of permanent tissue damage. 
Ultrasound-facilitated drug delivery has received increased interest due to its ability to 
enhance permeation of therapeutics through various biological barriers [16]. The technique 
has been safely used on ocular tissue, demonstrating an ability to enhance therapeutic 
permeation through both the cornea [17] and sclera [18]. In addition, preliminary studies have 
also investigated the technique as an adjunct to improve intravitreal drug migration. Here, the 
therapeutic is first injected into the vitreous together with an ultrasound-responsive contrast 
agent, such as micro- or nanobubbles, after which ultrasound is administered to the sclera of 
the eye (Fig 1). The contrast agent enhances the effect of the stimulus (be this cavitation or 
streaming) in a localized manner enabling the ultrasound to be used at low, biologically safe 
intensities. To date this technique has shown immense potential in improving ocular drug 
outcomes in small animal (rat) models [19, 20], although no reports currently exist showing it 
as a useful approach in larger animals whose eyes more closely resemble the dimensions and 
geometry of the human eye. 
In order to successfully implement the approach in the clinical setting, it is imperative to first 
study its effects in large animal models. As in vivo models incur sizeable cost and ethical 
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issues on such evaluations, a prudent initial approach is to exploit freshly excised ex vivo eyes 
to understand and optimize the strategy. Moreover, ex vivo models offer greater insight 
beyond cell culture into potential physical and, in certain cases, biochemical barriers that a 
therapeutic or drug delivery system may face in reaching its target. The ex vivo eye is now 
established as a robust model for therapeutic evaluations, with various biological structures 
retaining their properties for many hours following animal sacrifice [21-24]. 
In this study, ultrasound was used to influence the migration of nanobubbles in ex vivo 
vitreous humor. Studies evaluating the feasibility of the technique were initially performed 
and optimized using the larger ex vivo bovine eye, then transitioned to porcine eyes whose 
dimensions closely resemble those of humans. 
 
2 Experimental Section 
2.1 Materials 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG(2k)-OMe) were 
purchased from Avanti
®
 Polar Lipids (Alabaster, AL, USA). Perfluoropropane (PFP) was 
purchased from Coregas (Darra, QLD, Australia). 5-carboxy-tetramethylrhodamine N-
succinimidyl ester (5-TAMRA) was purchased from Okeanos Tech Co., Ltd. (Beijing, 
China). 
2.1.1 Bovine eyes 
The bovine eye was used as the benchmark model for evaluations as it could be sourced 
immediately post-mortem on a regular basis. Eyes were purchased from Teys Australia™ 
(Beenleigh, QLD, Australia). All experiments were performed within 8 h of sacrifice of the 
animal.  
2.1.2 Porcine eyes 
Given their restricted availability, porcine eye evaluations were conducted following 
completion of bovine eye optimization studies. Eyes were sourced from Pork Mart and 
Poultry (Greenlane, New Zealand). Due to the unavoidable aged nature of tissue (received 24 
h post-mortem), studies on ocular structures including the cornea, lens, sclera and retina were 
not performed. However, studies upon the vitreous humor were possible with this model as 
the humor retains its structural and mechanical properties for up to 60 h post-mortem [22, 
23].  
 
2.2 Preparation of tagged nanobubbles 
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Formulations were prepared as previously described [25, 26]. Briefly, DPPC, DSPE-
PEG(2k)-OMe and 5-TAMRA (92:6:2 molar ratio) were added to a round bottom flask and 
dissolved in chloroform. The flask was then mounted onto a rotary evaporator and the solvent 
was removed by heating under vacuum at 65 °C and 100 rpm to obtain a thin film. Next the 
film was hydrated with phosphate buffered saline (PBS, pH 7.4) to obtain a crude liposome 
mixture. This mixture was downsized using bath sonication and subsequently placed in an air 
evacuated crimp sealed vial. PFP was added to the vial using a gas tight syringe, pressurising 
the liposomes, which facilitated entrapment of the contrast agent. The vials were vigorously 
shaken under heat to ensure gas entrapment into the particles could be maximised. This 
process resulted in the formation of crude nanobubbles. The formed nanobubbles were 
further downsized by gas-tight extrusion through 400 nm polycarbonate membranes (Avanti
®
 
Polar Lipids, Alabaster, AL, USA). Following extrusion a residual foam layer was observed 
on the formulation. This layer was discarded to remove large particles and ensured only true 
nanobubble-sized particles were used in the study. Extruded and crude (unextruded) 
nanobubbles were characterized to identify differences in their size and polydispersity using a 
Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). Finally, echogenicity of both 
particles was evaluated using an Ellex
®
 EyeCubed imaging ultrasound unit equipped with a 
10 MHz sealed probe set to B-Scan mode (25 fps) [26], and quantified by derivation of the 
Mean Grayscale Value of the image using Adobe Photoshop CC (14.2). 
 
2.3 Intravitreal injection and therapeutic ultrasound administration technique in large 
mammal eyes 
An insulin syringe equipped with an 8 or 12.7 mm 30G needle was used for nanobubble 
injection into porcine and bovine eyes, respectively. A clinically relevant maximum volume 
of 100 µL was injected through the pars plana located at the temporal side of the eye. A slow 
injection speed (~3 s) was adopted to minimize uncontrollable distribution, with 
appropriately injected formulations manifesting as boluses posterior to the lens. Extraocular 
ultrasound (JUS-2, Johari
®
 Digital, Jodhpur, India) was applied (1 MHz, 50% [porcine] or 
100% [bovine] duty, 2.5 W/cm
2
, 60 s) using a 34 mm flat head probe via either the pars plana 
or cornea of the eye (Fig 1).  
 
2.4 Evaluations of ultrasound-triggered particle movement in large mammal eyes 
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2.4.1 Visual and optical fluorescence imaging 
An adapted partial dissection technique was employed to visualize the vitreous humor in 
bovine eyes [27]. Briefly, a defined section of the sclera located on the nasal side of the eye 
was excised to reveal the vitreous body. While keeping the vitreous humor intact, an artificial 
seal was prepared by affixing the opened portion of the eye to the lid of a P10 petri dish using 
cyanoacrylamide glue. Injected formulations could be visually observed through the prepared 
window. 
Optical fluorescence evaluations were employed to quantify intravitreal propagation of 
nanobubbles. Particle migration in the presence and absence of ultrasound was observed 
using an In-Vivo MS FX PRO imaging apparatus (Bruker, Billerica, MA, USA) at 530 nm 
Ex/590 nm Em with 15 s exposure and 190 mm field of view to allow simultaneous imaging 
of control and treatment eyes. Following image capture, eyes were demarcated into anterior 
and posterior hemispheres (as in Fig 1; AN + AF = anterior hemisphere, PN + PF = posterior 
hemisphere), and the proportion of nanobubble dose in either hemisphere before and 
following ultrasound application was quantified using ImageJ software. As unilateral 
movement was being evaluated, only the corneal administration strategy was investigated in 
this evaluation. 
2.4.2 Porcine eye snap freezing evaluations 
An adaptation of the whole globe snap freeze technique was used to quantify the extent of 
ultrasound-facilitated therapeutic migration around the porcine eye [28, 29]. Briefly, 
following intravitreal injection of dye and subsequent ultrasound administration, the whole 
eyeball was appropriately oriented and snap-frozen in liquid nitrogen.  
Following complete freezing, the eye was first divided across the equator and subsequently 
into nasal and temporal segments in order to obtain four distinct regions (as specified in Fig 
1). Vitreous humor was collected from each region into Eppendorf
®
 tubes and samples were 
centrifuged at 16,000 g for 25 min at 4 °C to sediment the collagen and any residual retinal 
material. Nanobubbles and 5-TAMRA readily separated from collagenous regions of the 
vitreous humor by centrifugation and no further extraction steps were necessary. The 
supernatant was collected and 5-TAMRA concentrations were evaluated by fluorescence 
(530 nm Ex/590 nm Em) using calibration curves prepared on the same day. 
See supplementary information for bovine and porcine tissue dissection technique, 
ultrasound administration strategies used and intraocular nanobubble stability profile. 
 
  
Page | 8  
 
2.5 Histological evaluations 
Any potential ultrasound-induced damage to ex vivo bovine tissue was assessed using 
histology. Tissue was fixed immediately following ultrasound application in 10% formalin 
for 72 h followed by dehydration in 70% ethanol for 24 h. Overnight de-fatting and clearing 
steps with ethanol (70%, 90%, 95%, 3x 100%; 1 h each) and xylene (30 min, 30 min, 40 min) 
were conducted before paraffin wax infiltration (1 h, 1.5 h, 1.5 h) and tissue embedding 
within a wax block. A microtome was used to obtain 4 µm tissue sections which were placed 
on non-charged slides for staining. Gross damage to both anterior and posterior structures 
was evaluated using haematoxylin and eosin (H&E) staining.  
 
2.6 Statistical analysis 
All values are shown as mean ± SD following experiments carried out using n≥3 independent 
samples unless clearly stated otherwise. A Shapiro-Wilk normality test was conducted to 
confirm the obtained data was normally distributed. Comparisons among groups were 
conducted using one-way or two-way ANOVA which featured a Dunnett’s multiple 
comparisons post-test, with p<0.05 being considered statistically significant. 
 
3 Results 
3.1 Extrusion processes improve nanobubble size distribution and gas entrapment 
While protein-based nanobubbles have previously been prepared with minimal size variation 
[30], robust protocols are not currently in place to achieve the same with lipid-based bubbles. 
Extrusion has been routinely used for liposomal/lipid nanoparticle downsizing and size 
standardization and its use in this evaluation achieved the same effect. Extruded nanobubbles 
demonstrated a Z-average size of 205.0 ± 35.3 nm and a polydispersity index of 0.331  
± 0.095. In contrast, crude nanobubbles were both larger (Z-average size: 606.4  
± 132.4 nm) and more heterogenous (polydispersity index: 0.496  
± 0.096). Surprisingly, the shear forces offered by extrusion also enhanced formulation 
echogenicity. A 12 µg/ml aliquot of extruded nanobubbles was approximately 3-fold more 
echogenic than the same concentration of crude nanobubbles (Fig 2). Additionally at this 
dilution, extruded nanobubbles were able to retain 71.6 ± 6.6% of their echogenicity over 30 
min, while the crude nanobubbles could only retain 26.4 ± 3.5% of their echogenicity. 
Finally, complete loss of echogenicity was observed when either nanobubble formulation was 
exposed to therapeutic JUS-2 ultrasound. 
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3.2 Ultrasonic cycles can migrate nanobubbles in bovine vitreous 
Nanobubble movement in the vitreous could be readily visualized using the employed optical 
fluorescence setup. Over the timeframe studied, no particle migration was observed in 
absence of ultrasound administration. Conversely, application of corneal ultrasound (1 MHz, 
100% duty, 2.5 W/cm
2
, 60 s) significantly promoted nanobubble migration towards the 
posterior segment (p<0.001, Fig 3). Three cycles of 60 s ultrasound exposure were each 
separated by 2 min to minimize the hyperthermic effects of the stimulus on the tissue. Using 
this protocol, it was observed that each additional cycle increased bulk transfer of the 
formulation into the posterior hemisphere of the vitreous humor. Region of interest analysis 
revealed that following bolus administration, <10% of the administered dose was present in 
the posterior half of the vitreous humor in all cases prior to ultrasound application (Fig 3). A 
single cycle of ultrasound resulted in an approximate 200% increase with 28.6 ± 8.5% of the 
dose rapidly transferring to the posterior region. Moreover, this transfer could be further 
increased by multiple cycles with 45.1 ± 11.4% and 47.8 ± 15.2% of the dose reaching the 
posterior vitreous after 2 and 3 ultrasonic cycles, respectively (p<0.01). Ultrasound was 
separately also administered to native dye and non-echogenic dye-containing liposomes 
injected into the vitreous humor. In both these cases, the stimulus had no impact on particle 
migration (data not shown). 
 
3.3 Impact of ultrasound on integrity of the ex vivo bovine eye 
Histological analysis revealed that optimized ultrasonic parameters had no identifiable impact 
on the integrity of any of the evaluated tissues, whether ultrasound was applied to the eye via 
the cornea or the sclera (Fig 4). The duration of ultrasound was extended to 240 s to assess 
whether this would affect tissue integrity and serve as a positive control (PC). Under these 
vastly exaggerated ultrasound application conditions damage was evident on regions of tissue 
adjacent to the probe application point following the prolonged corneal or pars plana 
administration; in the case of corneal ultrasound administration central clouding of the lens 
was observed whereas pars plana ultrasound administration induced substantial tissue 
dehydration and retinal delamination. Each of these features were readily identified as tissue 
damage when evaluated using histology (Fig 4F, 4I and 4L). 
 
3.4 Bolus migration can be evaluated using a snap freezing protocol in the ex vivo porcine 
eye 
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The phenomenon of ultrasound-assisted bolus bubble transfer was further investigated in the 
porcine eye model. Given its similarity in size and physiology to the human eye [31], it was 
postulated that findings in this model would be considered more clinically relevant.  
The snap freeze method was utilized to understand distribution of the formulation inside 
porcine eyes. An ultrasonic protocol of 1 MHz, 50% duty, 2.5 W/cm
2
, 60 s was employed for 
the porcine eye studies. Similar to the bovine model, particle migration was not observed in 
the porcine eye via simple convection in the absence of ultrasound. The two investigated 
ultrasound probe orientations (pars plana and corneal) had starkly contrasting outcomes on 
the path of nanobubble migration. In the case of pars plana administration, nanobubbles were 
primarily driven from the AN region into the AF region of the vitreous, with 56.5 ± 8.9% of 
the injected dose being transferred. This strategy resulted in a significantly greater AF 
nanobubble concentration than from the other two tested conditions (p<0.0001). In contrast, 
corneal administration resulted in the greatest proportion of nanobubbles transferring from 
the AN region into the PN region (36.3 ± 4.2% of injected dose transferred, p<0.0001, Fig 5). 
Neither approach elicited significant movement of the formulation to the PF region, which 
contained <10% of the administered formulation dose in all instances. 
 
4 Discussion 
The primary objective of this study was to determine whether the nanobubble-ultrasound 
strategy holds potential in improving the rapid, directional migration of therapeutics towards 
their target site in large animal models. Nanobubbles were chosen in place of simple dye or 
non-gaseous nanoparticles as prior evaluations demonstrated that gas entrapment played an 
essential role in driving particle responsiveness to ultrasound [26]. With standard formulation 
strategies failing to produce homogenous nanobubbles, we sought to utilize an extrusion 
technique to standardize bubble size. While extrusion was able to reduce both particle size 
and heterogeneity, it unexpectedly also increased gas content and so echogenicity of the 
resultant nanobubbles. This may be due to extrusion having improved the shell strength of the 
nanobubbles and therefore allowing these to better retain gas, and for extended periods. In 
contrast, crude nanobubbles were only subjected to sonication which, while an effective 
downsizing technique, has previously been reported to form less stable lipid membranes [32]. 
At present, extrusion processes are not in use for lipid nanobubble manufacture, however, our 
findings suggest that the technique holds potential in this application. An observed loss of 
nanobubble echogenicity following therapeutic ultrasound administration also confirmed that 
in spite of the novel extrusion process, the nanobubbles are still responsive to the applied 
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stimulus. With the extruded nanobubbles demonstrating superior size and echogenic 
properties, the crude nanobubbles were excluded from subsequent studies. 
Following preparation of our nanobubbles, we moved to evaluate their migration behaviour 
in bovine eyes. This model was an ideal choice for optimization studies due to the immediacy 
with which they could be sourced post-mortem. Initial observations demonstrated that 
ultrasound unequivocally migrated our nanobubbles inside the vitreous humor, likely through 
an acoustic streaming phenomena, which involves the generation of flow currents by 
sonic/ultrasonic waves within a liquid medium [33, 34]. While streaming phenomena have 
routinely been proposed as a mechanism by which ultrasound encourages cell/tissue 
internalization of a therapeutic, they have very rarely been proposed for bulk transport of 
therapeutic through a tissue [35, 36], as was observed with our nanobubble formulation. The 
use of streaming phenomena such as radiation-force in ultrasound-assisted drug migration has 
been restricted to pushing formulations across micrometre lengths e.g. towards capillary 
walls [37, 38]. Our observations suggest that, given the comparatively stagnant nature of the 
vitreous humor (c.f. blood flow), acoustic streaming may well be an ideal mechanism by 
which to encourage particle transfer within this and other media. Additionally, in our study, 
streaming was only observed when using gas-containing nanobubbles with ultrasound having 
no impact on movement of native dye or non-gaseous dye-containing liposomes, highlighting 
the importance of gas incorporation for the strategy to work more effectively.  
Although particle movement could be qualitatively observed in an intact bovine eye by visual 
observation through the cornea, surgical manipulation was essential in order to quantify the 
extent of that movement. Partial eye dissections are routinely employed in experimental 
procedures as they maintain integrity of the vitreous environment [27, 39, 40], thus a 
dissection of this nature was adopted as a direct measure of bubble migration. As the entire 
vitreous humor is retained within the eye and injection/ultrasound administration is carried 
out away from the surgically created viewing window, it is expected that findings from these 
evaluations closely approximate those occurring in an intact eye. 
Regulatory guidelines currently in place put strong emphasis on the physiological 
compatibility of devices administered on/to the eye, notably requiring caution to be exercised 
when using devices that may increase ocular temperature [41, 42]. This factor was important 
to keep in mind during our evaluation, with ultrasound being well known to dissipate as 
thermal energy. The tissue was able to withstand 60 s of our employed ultrasound protocol, 
although increasing the duration caused a visible loss of tissue rigidity. The effects of 
prolonged exposure (240 s) were clearly visible with histology; while the cornea appeared to 
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withstand prolonged ultrasound, the stimulus severely affected each of the lens, sclera and 
retina. This provided invaluable information on the maximum duration that the stimulus 
could be applied using our ultrasound apparatus. 
To counter these detrimental effects, we pursued the use of multiple cycles of ultrasound 
separated by stimulus-free intervals for tissue recovery. This strategy effectively mitigated 
the adverse potential of ultrasound, while each additional cycle served to further enhance 
directional bubble migration. As such, adopting a similar strategy when taking this technique 
forward to maximize the outcomes of ultrasound administration in a safe manner would be 
prudent. 
Comparisons between pars plana and corneal surface-delivered ultrasound in the porcine eye 
clearly demonstrated that probe orientation greatly impacts the direction of particle 
movement. This is unsurprising as the direction of a generated acoustic stream will typically 
be determined by the source of the impulse in the absence of other counter-streams. While 
particles generally moved in a directional manner away from the applied ultrasound source, it 
was interesting to note that only a limited quantity of bubbles reached the PF region. This 
may be due to the heterogenous vitreous restricting particle movement in certain directions 
[29, 43] or constraints brought about by the design of the utilized ultrasound probe/device, 
although further studies that more precisely characterize ultrasonic wave propagation through 
the vitreous humor are necessary in order to fully understand the inability to attain PF 
deposition. As we were only able to measure dye concentrations, it is also unclear whether 
the observed migration was due to ultrasound propelling the nanobubbles or ultrasound 
displacing and dispersing the 5-TAMRA from the nanobubbles. It is envisaged that this 
strategy will be used to assist migration of large therapeutics such as antibodies and peptides, 
thus it is important in future evaluations incorporate macromolecules into the formulation and 
assess how ultrasound influences their release from the system and transport toward their 
target. 
Importantly, this study has demonstrated the ability to rapidly migrate highly echogenic 
nanobubbles to the posterior regions of the vitreous humor. There appears to be immense 
benefit from being able to do so, with computational models having previously determined 
that a drug bolus residing closer to the target site in the retina will achieve superior Cmax and 
AUC in adjacent retinal tissues [15]. With the end goal being improvements in retinal drug 
delivery, future studies will look into using the ultrasound/nanobubble approach in an in vivo 
model using a custom-designed ophthalmic ultrasound probe/device. These studies will also 
help evaluate how physiological phenomena such as intraocular convection may influence the 
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effectiveness of our strategy. We anticipate that ultrasound will be able to work together with 
convective flow and further enhance therapeutic migration to the posterior eye. Emphasis 
should remain on utilizing large animal models with physiological similarities to the human 
eye in order to attain clinically relevant outcomes. 
5 Conclusion 
The ultrasound-nanobubble strategy was investigated and optimized in two independent ex 
vivo large mammal eye models. Acoustic streaming was seen as the primary driving factor 
for ultrasound-assisted intravitreal particle migration, with only gaseous particles being able 
to migrate under the assessed conditions. Bovine eye studies revealed that repeated cycles of 
corneal ultrasound could improve the migration of injected nanobubbles deeper into the 
posterior regions of the vitreous humor while causing no observable acute damage to the 
ocular tissues. Porcine eye studies demonstrated that the orientation of the applied ultrasound 
impulse could control the direction of nanobubble migration.  
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Figure 1. Schematic depicting investigated modes of therapeutic ultrasound administration to 
the bovine and porcine eye. The lens of the eye has been included to clarify the orientation of 
the ultrasound probe and injected formulation bolus in relation to the other ocular structures. 
The vitreous was divided in four sections in relation to the site of injection and bolus; AN = 
anterior near, AF = anterior far, PN = posterior near, PF = posterior far. The near regions 
correspond to the temporal side of the eye whereas the far regions correspond to the nasal 
side of the eye. Probe size not to scale. 
Figure 2. Impact of gastight extrusion on the 30 minute echogenic profile of DPPC:DSPE-
PEG(2k)-OMe nanobubbles in PBS (pH 7.4). Signals correspond to 600 µg (100 µL) of lipid 
dispersed in 50 mL of PBS, with measurements being taken from grayscale image provided 
by Ellex
®
 EyeCubed ultrasound system. A higher grayscale value corresponds to a greater in-
formulation gas content. 
Figure 3. Migration of rhodamine nanobubbles into posterior regions of bovine vitreous 
following three cycles of corneal ultrasound administration (1 MHz, 100% duty, 2.5 W/cm
2
, 
60 s). Sixty second long cycles were administered 2, 5, and 8 min following injection. Tissue 
was demarcated into anterior and posterior regions and the fluorescence intensity in each was 
compared to provide the percentage of formulation that had reached the posterior vitreous. 
Differences in formulation concentrations were analyzed using one-way ANOVA. 
Figure 4. Sample images from histological evaluations demonstrating the impact of 
ultrasound exposure (1 MHz, 100% duty, 2.5 W/cm
2
, 60 s) on ocular tissues in comparison to 
healthy (control) and damaged (ultrasound administration prolonged to 240 s, PC) tissue. In 
the case of cornea and lens sections ultrasound was administered in a transcorneal fashion, 
whereas in the case of sclera and retina sections it was administered in a trans-scleral fashion 
through the pars plana. Damage clearly visible in panels F, I and L has been identified using 
an asterisk*. Scale bar = 400 µm for sclera sections, 200 µm for all other sections. Key: CE = 
corneal epithelium, Ch = choroid, PC = positive control. 
Figure 5. Distribution of rhodamine nanobubbles following convection, pars plana- or 
corneal- ultrasound administration. Parameters of 1 MHz, 50% duty, 2.5 W/cm
2
, 60 s were 
used. The vitreous was divided into four sections in relation to the site of injection and bolus; 
AN = anterior near, AF = anterior far, PN = posterior near, PF = posterior far, US = 
ultrasound. The near regions correspond to the temporal side of the eye whereas the far 
regions correspond to the nasal side of the eye. Statistical analysis by two-way ANOVA with 
Dunnett’s multiple comparisons post-hoc test. **** p < 0.0001 compared with other 
treatments within same section. 
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